Ray Rendon III

Ray Rendon III is a seasoned professional in the cell and gene therapy sector, currently serving as a Senior Corporate Account Executive at BioBridge Global since October 2023, where responsibilities include supplying quality source materials for advanced therapies. Previously, as an Account Executive at Title21 Health Solutions, Ray introduced a digital platform to enhance workflows for Blood and Marrow Transplant Centers. Other experiences include roles as Application Development Manager at CPC, where innovative sterile connection technology was developed, and various positions at OriGen Biomedical, focusing on sales and technical support in the cell and gene therapy industry. Ray's career began at MD Anderson Cancer Center as a Clinical Cell Therapy Specialist, manufacturing clinical products in cGMP settings. Educational credentials include a BS in Microbiology from Texas A&M University and a BS in Clinical Laboratory Science from the University of Texas at MD Anderson Cancer Center.